Javascript must be enabled to continue!
Liver-spleen attenuation ratio in unenhanced and contrast enhanced computerized tomography in different grades of hepatic steatosis
View through CrossRef
Objective: To assess the average liver-spleen attenuation ratio on both plain and contrast-enhanced computed tomography (CECT) scan in various stages of hepatic steatosis. Method: The descriptive, cross-sectional study was conducted at the Department of Radiology, Dow University of Health Sciences/Dr Ruth K.M. Pfau Civil Hospital, Karachi, from February 1, 2017, to July 31, 2024, and comprised patients aged 15-85 years of either gender who underwent abdominal computed tomography scans for various non-hepatic indications. The liver-spleen attenuation ratio was measured as the ratio of Hounsfield unit values of the hepatic and splenic parenchyma before and after administering contrast for computed tomography scanning, with simultaneous recording of the hepatic steatosis grade via abdominal sonography. The mean liver-spleen attenuation ratios for different stages of hepatic steatosis severity were analysed for both pre- and post-contrast computed tomography scans. Data was analysed using SPSS 21. Result: Of the 334 patients, 206(61.7%) were females and 128(38.3%) were males. The overall mean age was 45.26±11.61 (30-70) years. The mean liver-spleen attenuation ratio values on pre- and post-contrast scans were 0.71±0.08 and 0.72±0.09 for mild, 0.61±0.08 and 0.65±0.13 for moderate, and 0.02±0.72 and 0.36±0.20 for severe steatosis, respectively, as against sonographic hepatic steatosis grading. The overall mean liver-spleen attenuation ratio was 0.49±0.45 for pre- and 0.60±0.20 for post-contrast scans. Complications such as dilated portal vein (p<0.001), dilated splenic vein(p<0.001), splenomegaly (p<0.001), abdominal collaterals (p<0.001), and ascites (p=0.014) were significantly more frequent in those with L/S ratio of 0.7 or less on CECT. Conclusion: The liver-spleen attenuation ratio decreased in fatty liver disease on both pre- and post-contrast computed tomography scans, with a more noticeable reduction seen on the post-contrast images, and with advanced grades of steatosis.
Key Words: Liver-spleen attenuation ratio, Hepatic steatosis, Computerised tomography, CT, Ultrasound, Grades of hepatic steatosis, Unenhanced, Contrast-enhanced CT.
Pakistan Medical Association
Title: Liver-spleen attenuation ratio in unenhanced and contrast enhanced computerized tomography in different grades of hepatic steatosis
Description:
Objective: To assess the average liver-spleen attenuation ratio on both plain and contrast-enhanced computed tomography (CECT) scan in various stages of hepatic steatosis.
Method: The descriptive, cross-sectional study was conducted at the Department of Radiology, Dow University of Health Sciences/Dr Ruth K.
M.
Pfau Civil Hospital, Karachi, from February 1, 2017, to July 31, 2024, and comprised patients aged 15-85 years of either gender who underwent abdominal computed tomography scans for various non-hepatic indications.
The liver-spleen attenuation ratio was measured as the ratio of Hounsfield unit values of the hepatic and splenic parenchyma before and after administering contrast for computed tomography scanning, with simultaneous recording of the hepatic steatosis grade via abdominal sonography.
The mean liver-spleen attenuation ratios for different stages of hepatic steatosis severity were analysed for both pre- and post-contrast computed tomography scans.
Data was analysed using SPSS 21.
Result: Of the 334 patients, 206(61.
7%) were females and 128(38.
3%) were males.
The overall mean age was 45.
26±11.
61 (30-70) years.
The mean liver-spleen attenuation ratio values on pre- and post-contrast scans were 0.
71±0.
08 and 0.
72±0.
09 for mild, 0.
61±0.
08 and 0.
65±0.
13 for moderate, and 0.
02±0.
72 and 0.
36±0.
20 for severe steatosis, respectively, as against sonographic hepatic steatosis grading.
The overall mean liver-spleen attenuation ratio was 0.
49±0.
45 for pre- and 0.
60±0.
20 for post-contrast scans.
Complications such as dilated portal vein (p<0.
001), dilated splenic vein(p<0.
001), splenomegaly (p<0.
001), abdominal collaterals (p<0.
001), and ascites (p=0.
014) were significantly more frequent in those with L/S ratio of 0.
7 or less on CECT.
Conclusion: The liver-spleen attenuation ratio decreased in fatty liver disease on both pre- and post-contrast computed tomography scans, with a more noticeable reduction seen on the post-contrast images, and with advanced grades of steatosis.
Key Words: Liver-spleen attenuation ratio, Hepatic steatosis, Computerised tomography, CT, Ultrasound, Grades of hepatic steatosis, Unenhanced, Contrast-enhanced CT.
Related Results
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED]Product Name - Bridport Health Ingredients - Milk Thistle, Beetroot, Artichoke Extract & More. Category - Liver Support Supplement Main Benefits - Helps Protect The ...
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED]Depiction • Where to Get Bottle Online –Click Here • Item Name -Bridport Health Liver • Aftereffects - No Major Side Effects • Classification - Health • Accessibility -O...
Spleen and Liver Fibrosis Is Associated to Treatment Response and Prognosis in Philadelphia-Negative Chronic Myeloproliferative Neoplasms
Spleen and Liver Fibrosis Is Associated to Treatment Response and Prognosis in Philadelphia-Negative Chronic Myeloproliferative Neoplasms
Abstract
Introduction: Spleen and liver stiffness, investigated by transient elastography (TE), have been associated with marrow fibrosis in patients...
Differential effects of systemic immune inflammation indices on hepatic steatosis and hepatic fibrosis: evidence from NHANES 1999-2018
Differential effects of systemic immune inflammation indices on hepatic steatosis and hepatic fibrosis: evidence from NHANES 1999-2018
Abstract
Background
Several studies have demonstrated that systemic immune inflammation index (SII) has a positive relationship with hepatic steatosis. However, it is lack...
Gut microbiota changes and novel markers associated with liver steatosis in obese patients
Gut microbiota changes and novel markers associated with liver steatosis in obese patients
Background. Liver steatosis is a common condition that can progress to steatohepatitis, fibrosis, and cirrhosis and increases the risk of death from cardiovascular and liver compli...
A Practical Approach to Quantitative Grayscale Ultrasound Analysis of Hepatic Steatosis in Pediatric Patients Using a Picture Archiving and Communication System–Based Tool
A Practical Approach to Quantitative Grayscale Ultrasound Analysis of Hepatic Steatosis in Pediatric Patients Using a Picture Archiving and Communication System–Based Tool
ObjectivesTo evaluate the efficacy of a picture archiving and communication system (PACS)‐based ultrasound (US) quantification technique for diagnosis of hepatic steatosis in a ped...
Diagnosis of hepatic steatosis based on ultrasound attenuation imaging is not influenced by liver fibrosis
Diagnosis of hepatic steatosis based on ultrasound attenuation imaging is not influenced by liver fibrosis
AbstractAimRecently, a new technique using attenuation imaging (ATI) was developed to diagnose hepatic steatosis. The aim of this study was to investigate whether ATI for the evalu...
Correlation Between COVID-19 Severity, Body Mass Index and Hepatic Steatosis: A Retrograde Cohort Study
Correlation Between COVID-19 Severity, Body Mass Index and Hepatic Steatosis: A Retrograde Cohort Study
Abstract
Background Obesity and fatty liver steatosis are already considered metabolic risk factors that may aggravate the severity of COVID-19. This study aims to investig...

